A study on vascular endothelial growth factor and endothelin-1 in patients with extra-articular involvement of rheumatoid arthritis

Clinical Rheumatology

Volumn 25, Issue 3, 2006, Pages 314-319

  Kuryliszyn Moskal, Anna ^a   Klimiuk, Piotr Adrian ^a   Sierakowski, Stanisław ^a   Ciolkiewicz, Mariusz ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

ET 1; RA; Systemic involvement; VEGF

Indexed keywords

C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ENDOTHELIN 1; GOLD; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; SALAZOSULFAPYRIDINE; VASCULOTROPIN;

ADULT; AGED; AMYLOIDOSIS; ARTHRALGIA; ARTICLE; CELL ACTIVATION; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GLOMERULONEPHRITIS; HUMAN; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

AMYLOIDOSIS; ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; ENDOTHELIN-1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULONEPHRITIS; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PULMONARY FIBROSIS; SEVERITY OF ILLNESS INDEX; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33645773426     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-005-0007-2     Document Type: Article

References (41)

1. Firestein GS (1997) Etiology and pathogenesis of rheumatoid arthritis. In: Kelley WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of rheumatology, Saunders, Philadelphia pp 851-897
2. Tak PP, Bresnihan B (2000) The pathogenesis and prevention of joint damage in rheumatoid arthritis. Advances from synovial biopsy and tissue analysis. Arthritis Rheum 43:2619-2633
3. Sany J (1995) Clinical and immunopathological extraarticular manifestations of rheumatoid arthritis. Rheumatol Eur 24(suppl):175-178
4. Turesson C, Jacobsson LTH (2004) Epidemiology of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol 33:65-72
5. Bacon PA, Kitas GD (1994) The significance of vascular inflammation in rheumatoid arthritis. Ann Rheum Dis 53:621-623
6. Krishnaswamy G, Kelley J, Yerra L, Smith JK, Chi DS (1999) Human endothelium as a source of multifunctional cytokines: Molecular regulation and possible role in human disease. J Interferon Cytokine Res 19:91-104
7. Paleolog EM (1996) Angiogenesis: A critical process in the pathogenesis of RA - a role for VEGF? Br J Rheumatol 35:917-920
8. Koch AE (2000) The role of angiogenesis in rheumatoid arthritis - recent development. Ann Rheum Dis 59:465-471
9. Brenchley PEC (2001) Antagonising angiogenesis in rheumatoid arthritis. Ann Rheum Dis 60:iIi71-iii74
10. Harada M, Mitsuyama K, Yoshida H, Sakisaka S, Taniguchi E, Kawaguchi T, Ariyoshi M, Saiki T, Sakamoto M, Nagata K, Sata M, Matsuo K, Tanikawa K (1998) Vascular endothelial growth factor in patients with rheumatoid arthritis. Scand J Rheumatol 27:377-380
11. Lee SS, Joo YS, Kim WU, Min DJ, Min JK, Park SH, Cho CS, Kim HY (2001) Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 19:321-324
12. Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik JP, Cylwik B, Skowronski J, Chwiecko J (2002) Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis. Ann Rheum Dis 61:804-809
13. Mayes MD (2003) Endothelin and endothelin receptor antagonists in systemic rheumatic disease. Arthritis Rheum 48:1190-1199
14. Yoshio T, Masuyama J, Mimori A, Takeda A, Minota S, Kano S (1995) Endothelin-1 release from cultured endothelial cells induced by sera from patients with systemic lupus erythematosus. Ann Rheum Dis 54:361-365
15. Vancheeswaran R, Magoulas T, Efrat G, Wheeler-Jones C, Olsen I, Penny R, Black CM (1994) Circulating endothelin-1 levels in systemic sclerosis subsets - a marker of fibrosis or vascular dysfunction? J Rheumatol 21:1838-1844
16. Haq A, El-Ramahi K, Al-Dalaan A, Al-Sedairy ST (1999) Serum and synovial fluid concentrations of endothelin-1 in patients with rheumatoid arthritis. J Med 30:51-60
17. Kuryliszyn-Moskal A, Bernacka K, Klimiuk PA (1996) Circulating intercellular adhesion molecule 1 in rheumatoid arthritis - relationship to systemic vasculitis and microvascular injury in nailfold capillary microscopy. Clin Rheumatol 15:367-373
18. Kuryliszyn-Moskal A, Klimiuk PA, Sierakowski S (2001) Serum autoantibodies profile and increased levels of circulating intercellular adhesion molecule-1: A reflection of the immunologically mediated systemic vasculopathy in rheumatic diseases? Arch Immunol Ther Exp 49:423-430
19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
20. Prevoo MLL, Van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LBA, van Riel PLCM (1995) Modified disease activity scores that include twenty-eight joint counts: Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44-48
21. Szekanecz Z, Szegedi G, Koch AE (1998) Angiogenesis in rheumatoid arthritis: Pathogenic and clinical significance. J Investig Med 46:27-41
22. Koch AE (2003) Angiogenesis as a target in rheumatoid arthritis. Ann Rheum Dis 62 (suppl II):iI60-ii67
23. Van Doornum S, McColl G, Jenkins A, Green DJ, Wicks IP (2003) Screening for atherosclerosis in patients with rheumatoid arthritis: Comparison of two in vivo tests of vascular function. Arthritis Rheum 48:72-80
24. Vaudo G, Marchesi S, Gerli R, Allegrucci R, Giordano A, Siepi D, Pirro M, Shoenfeld Y, Schillaci G, Mannarino E (2004) Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 63:31-35
25. Sundy JS, Haynes BF (1995) Pathogenic mechanisms of vessel damage in vasculitis syndromes. Rheum Dis Clin North Am 21:861-881
26. Verschueren PC, Voskuyl AE, Smeets TJ, Zwinderman KH, Breedveld FC, Tak PP (2000) Increased cellularity and expression of adhesion molecules in muscle biopsy specimens from patients with rheumatoid arthritis with clinical suspicion of vasculitis, but negative routine histology. Ann Rheum Dis 59:598-606
27. DeMaria AN (2002) Relative risk of cardiovascular events in patients with rheumatoid arthritis. J Cardiol 89(suppl):33d-38d
28. Manzi S, Waasko MC (2000) Inflammation-mediated rheumatic diseases and atherosclerosis. Ann Rheum Dis 59:321-325
29. Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE et al (2003) Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107:1297-1301
30. Clancy R, Marder G, Martin V, Belmont HM, Abramson SB, Buyon J (2001) Circulating activated endothelial cells in systemic lupus erythematosus. Further evidence for diffuse vasculopathy. Arthritis Rheum 44:1203-1208
31. Kikuchi K, Kubo M, Kadono T, Yazawa N, Ihn H, Tamaki K (1998) Serum concentrations of vascular endothelial growth factor in collagen diseases. Br J Dermatol 139:1049-1051
32. Ferrara N (1999) Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77:527-543
33. Kasama T, Shiozawa F, Kobayashi K, Yajima N, Hanyuda M, Takeuchi HT, Mori Y, Negishi M, Ide H, Adachi M (2001) Vascular endothelial growth factor expression by activated synovial leukocytes in rheumatoid arthritis. Arthritis Rheum 44:2512-2524
34. Paleolog EM, Young S, Stark AC, McCloskey RV, Feldmann M, Maini RN (1998) Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor α and interleukin-1 in rheumatoid arthritis. Arthritis Rheum 41:1258-1265
35. Mayes MD (2003) Endothelin and endothelin receptor antagonists in systemic rheumatic disease. Arthritis Rheum 48:1190-1199
36. Xu S, Denton CP, Holmes A, Dashwood MR, Abraham DJ, Black CM (1998) Endothelins: Effect on matrix biosynthesis and proliferation in normal and scleroderma fibroblasts. J Cardiovasc Pharmacol 31 (suppl 1):S360-S363
37. Matsuda J, Tsukamoto M, Gohchi K, Saitoh N, Miyajima Y, Kazama M (1992) Effect of total-body cold exposure on plasma concentrations of von Willebrand factor, endothelin-1 and thrombomodulin in systemic lupus erythematosus patients with or without Raynaud's phenomenon. Acta Haematol 88:189-193
38. Filep JG, Bodolay E, Sipka S, Gyimesi E, Csipo I, Szegedi G (1995) Plasma endothelin correlates with antiendothelial antibodies in patients with mixed connective tissue disease. Circulation 92:2969-2974
39. Morelli S, Ferri C, Polettini E, Bellini C, Gualdi GF, Pittoni V et al (1995) Plasma endothelin-1 levels, pulmonary hypertension, and lung fibrosis in patients with systemic sclerosis. Am J Med 99:255-260
40. Akazawa H, Ikeda U, Kuroda T, Shimada K (1996) Plasma endothelin-1 levels in Takayasu's arteritis. Cardiology 87:303-305
41. Pache M, Schwarz HA, Kaiser HJ, Wüest P, Klöti M, Dubler B, Flammer J (2002) Elevated plasma endothelin-1 levels and vascular dysregulation in patients with rheumatoid arthritis. Med Sci Monit 8:CR616-CR619